Addex Therapeutics Ltd (SWX:ADXN)
Switzerland flag Switzerland · Delayed Price · Currency is CHF
0.0420
+0.0014 (3.45%)
Jul 31, 2026, 5:30 PM CET

Addex Therapeutics Ratios and Metrics

Millions CHF. Fiscal year is Jan - Dec.

Total Valuation

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jul '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
56661039
Market Cap Growth
-11.53%14.83%-9.01%-40.48%-73.65%-25.96%
Enterprise Value
4422024
Last Close Price
0.040.060.060.050.101.04

Price Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jul '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PE Ratio
--0.80---
PS Ratio
45.7737.3613.723.827.1912.50
PB Ratio
1.521.360.585.402.112.33
P/TBV Ratio
1.521.360.585.402.112.33

EV Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jul '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
EV/Sales Ratio
38.1624.925.661.080.287.76

Financial Efficiency

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jul '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Debt / Equity Ratio
0.030.010.000.300.080.03
Net Debt / Equity Ratio
-0.25-0.34-0.34-3.07-1.34-1.18
Net Debt / EBITDA Ratio
0.310.571.291.580.631.32
Net Debt / FCF Ratio
0.360.740.610.440.401.36
Asset Turnover
0.020.020.050.250.090.15
Quick Ratio
0.791.384.191.392.305.03
Current Ratio
0.971.404.421.462.385.31
Return on Equity (ROE)
-122.28%-94.75%-90.72%-82.53%-98.92%-97.35%
Return on Assets (ROA)
-23.59%-20.64%-22.48%-21.69%-42.75%-45.37%
Return on Capital Employed (ROCE)
-76.00%-54.50%-27.90%-128.30%-210.80%-84.20%

Yields

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jul '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Earnings Yield
-139.03%-104.18%125.46%-170.78%-200.32%-38.95%
FCF Yield
-46.66%-33.62%-95.57%-129.41%-158.28%-37.39%
Buyback Yield / Dilution
-14.34%-9.44%-32.04%-64.45%-32.43%-27.88%